US cannabis consumers and patients are asking questions like: will my local shop close? Will delivery be an option? Cannabis Wire is tracking cannabis regulators’ announcements.
Amid the COVID-19 pandemic, a dilemma has hit the nascent industry: to close or not to close? We’re keeping track of how companies, and regulators, are reacting.
Consumer Brands Association—think Kellogg's, Pepsi, etc.—has created a high-voltage advisory board to frame its advocacy approach.
A complicated but lucrative industry draws eager investors and lots of lawyers, brokers, and advisers to serve them. Most are honest. But not all.
Crapo laid out “significant concerns” about the SAFE Banking Act on Wednesday, suggesting a 2% THC cap on products eligible for financial services.
Here’s what we found from the last two years: Hundreds of complaints, ranging from false data about THC content to obscenely positioned gummies.
Representatives from JPMorgan Chase and the Peoples Bank North Carolina outlined the complex and confusing process involved in serving the cannabis industry.
The union represents more cannabis workers than any other in the US, and wants labor peace agreements baked into the legalization plans taking shape across the northeast.
Losses widened year-over-year, while net revenue declined 15 percent from the previous quarter, for the world’s highest-valued cannabis company.
Today, guidance was released for cannabis companies due to the "higher than usual crossover of financial interests" in the industry.
Cannabis Wire caught up with the Canopy Growth founder and former CEO on his decision to join Vireo Health as executive chairman.
The former CEO of Canopy Growth could receive up to 15 million shares for his role at the multistate cannabis company.
Aphria Reports a Second Consecutive Profitable Quarter, While Some Investors Share Concern Over Canadian Market
During an earnings call on Tuesday, Aphria emphasized Canadian growth opportunities against what some investors see as a disappointing first year of adult-use sales in the country.
Stock exchanges in Canada, Australia, and Jamaica talk to Cannabis Wire about how closely they’re watching US cannabis legislation that could change the international economic landscape.
Less than ten months after the companies agreed that MedMen would acquire PharmaCann, one of the biggest deals in cannabis history came to an end.
What regions get to apply a geographical label to its cannabis? Does an international perspective help? Should a name be connected to the land?